Name: induction and diagnosis of tumors in drosophila imaginal disc epithelia
Uploaded: 2017-07-25T14:00:00
Description: Watch this Scientific Journal Video about Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia at JoVE.com

We thank J. Vaughen for critical reading of the manuscript. This work was supported by grants from JSPS KAKENHI Grant Numbers 26891025, 15H01500 and The Takeda Science Foundation Research Grant to Y.T.

1. Fly Crosses and Clone Induction
<ol>
	<li>Remove all flies in the vial 12 h before collecting virgin flies.</li>
	<li>Anesthetize the flies in the vial by injecting CO2 gas and place flies onto a CO2 fly pad.</li>
	<li>Transfer 10 - 20 virgin females and 10 males from the CO2 fly pad into a fresh vial and incubate for 1 day at 25 &#176;C.</li>
	<li>Transfer these flies into a fresh vial and incubate for 12 h at 25 &#176;C. 
	NOTE: Discard the first vial as virgin females do not ...

<ol>
	<li>Hanahan, D., Weinberg, R. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+hallmarks+of+cancer.">The hallmarks of cancer.</a> Cell. 100 (1), 57-70 (2000).</li><li>Xu, T., Rubin, G. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Analysis+of+genetic+mosaics+in+developing+and+adult+Drosophila+tissues.">Analysis of genetic mosaics in developing and adult Drosophila tissues.</a> Development. 117 (4), 1223-1237 (1993).</li><li>Struhl, G., Basler, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Organizing+activity+of+wingless+protein+in+Drosophila.">Organizing activity of wingless protein in Drosophila.</a> Cell. 72 (4), 527-540 (1993).</li><li>Potter, C. J., Turenchalk, G. S., Xu, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Drosophila+in+cancer+research.+An+expanding+role.">Drosophila in cancer research. An expanding role.</a> Trends Genet. 16 (1), 33-39 (2000).</li><li>Miles, W. O., Dyson, N. J., Walker, J. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Modeling+tumor+invasion+and+metastasis+in+Drosophila.">Modeling tumor invasion and metastasis in Drosophila.</a> Dis Model Mech. 4 (6), 753-761 (2011).</li><li>Tipping, M., Perrimon, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Drosophila+as+a+model+for+context-dependent+tumorigenesis.">Drosophila as a model for context-dependent tumorigenesis.</a> J Cell Physiol. 229 (1), 27-33 (2013).</li><li>Bilder, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Epithelial+polarity+and+proliferation+control:+links+from+the+Drosophila+neoplastic+tumor+suppressors.">Epithelial polarity and proliferation control: links from the Drosophila neoplastic tumor suppressors.</a> Genes Dev. 18 (16), 1909-1925 (2004).</li><li>Humbert, P. O., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Control+of+tumourigenesis+by+the+Scribble/Dlg/Lgl+polarity+module.">Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module.</a> Oncogene. 27 (55), 6888-6907 (2008).</li><li>Huang, L., Muthuswamy, S. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Polarity+protein+alterations+in+carcinoma:+a+focus+on+emerging+roles+for+polarity+regulators.">Polarity protein alterations in carcinoma: a focus on emerging roles for polarity regulators.</a> Curr Opin Genet Dev. 20 (1), 41-50 (2010).</li><li>Brumby, A. M., Richardson, H. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=scribble+mutants+cooperate+with+oncogenic+Ras+or+Notch+to+cause+neoplastic+overgrowth+in+Drosophila.">scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila.</a> EMBO J. 22 (21), 5769-5779 (2003).</li><li>Igaki, T., Pastor-Pareja, J. C., Aonuma, H., Miura, M., Xu, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Intrinsic+tumor+suppression+and+epithelial+maintenance+by+endocytic+activation+of+Eiger/TNF+signaling+in+Drosophila.">Intrinsic tumor suppression and epithelial maintenance by endocytic activation of Eiger/TNF signaling in Drosophila.</a> Dev Cell. 16 (3), 458-465 (2009).</li><li>Tamori, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Involvement+of+Lgl+and+Mahjong/VprBP+in+cell+competition.">Involvement of Lgl and Mahjong/VprBP in cell competition.</a> PLoS Biol. 8 (7), e1000422 (2010).</li><li>Cordero, J. B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Oncogenic+Ras+diverts+a+host+TNF+tumor+suppressor+activity+into+tumor+promoter.">Oncogenic Ras diverts a host TNF tumor suppressor activity into tumor promoter.</a> Dev Cell. 18 (6), 999-1011 (2010).</li><li>Yamamoto, M., Ohsawa, S., Kunimasa, K., Igaki, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+ligand+Sas+and+its+receptor+PTP10D+drive+tumour-suppressive+cell+competition.">The ligand Sas and its receptor PTP10D drive tumour-suppressive cell competition.</a> Nature. 542 (7640), 246-250 (2017).</li><li>Vaughen, J., Igaki, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Slit-Robo+Repulsive+Signaling+Extrudes+Tumorigenic+Cells+from+Epithelia.">Slit-Robo Repulsive Signaling Extrudes Tumorigenic Cells from Epithelia.</a> Dev Cell. 39 (6), 683-695 (2016).</li><li>Tamori, Y., Suzuki, E., Deng, W. -. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Epithelial+Tumors+Originate+in+Tumor+Hotspots,+a+Tissue-Intrinsic+Microenvironment.">Epithelial Tumors Originate in Tumor Hotspots, a Tissue-Intrinsic Microenvironment.</a> PLoS Biol. 14 (9), e1002537 (2016).</li><li>Ohsawa, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Elimination+of+oncogenic+neighbors+by+JNK-mediated+engulfment+in+Drosophila.">Elimination of oncogenic neighbors by JNK-mediated engulfment in Drosophila.</a> Dev Cell. 20 (3), 315-328 (2011).</li><li>Men&#233;ndez, J., P&#233;rez-Garijo, A., Calleja, M., Morata, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+tumor-suppressing+mechanism+in+Drosophila+involving+cell+competition+and+the+Hippo+pathway.">A tumor-suppressing mechanism in Drosophila involving cell competition and the Hippo pathway.</a> Proc Natl Acad Sci U S A. 107 (33), 14651-14656 (2010).</li><li>Hogan, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Characterization+of+the+interface+between+normal+and+transformed+epithelial+cells.">Characterization of the interface between normal and transformed epithelial cells.</a> Nat Cell Biol. 11 (4), 460-467 (2009).</li><li>Kajita, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Interaction+with+surrounding+normal+epithelial+cells+influences+signalling+pathways+and+behaviour+of+Src-transformed+cells.">Interaction with surrounding normal epithelial cells influences signalling pathways and behaviour of Src-transformed cells.</a> J Cell Sci. 123 (Pt 2), 171-180 (2010).</li><li>Norman, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Loss+of+Scribble+causes+cell+competition+in+mammalian+cells.">Loss of Scribble causes cell competition in mammalian cells.</a> J Cell Sci. 125 (1), 59-66 (2012).</li><li>Wagstaff, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mechanical+cell+competition+kills+cells+via+induction+of+lethal+p53+levels.">Mechanical cell competition kills cells via induction of lethal p53 levels.</a> Nat Commun. 7, 1-14 (2016).</li><li>Kajita, M., Fujita, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=EDAC:+Epithelial+defence+against+cancer-cell+competition+between+normal+and+transformed+epithelial+cells+in+mammals.">EDAC: Epithelial defence against cancer-cell competition between normal and transformed epithelial cells in mammals.</a> J Biochem. 158 (1), 15-23 (2015).</li><li>North, A. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Seeing+is+believing?+A+beginners'+guide+to+practical+pitfalls+in+image+acquisition.">Seeing is believing? A beginners' guide to practical pitfalls in image acquisition.</a> J Cell Biol. 172 (1), 9-18 (2006).</li><li>Schindelin, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Fiji:+an+open-source+platform+for+biological-image+analysis.">Fiji: an open-source platform for biological-image analysis.</a> Nat Methods. 9 (7), 676-682 (2012).</li><li>Brand, A. H., Perrimon, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Targeted+gene+expression+as+a+means+of+altering+cell+fates+and+generating+dominant+phenotypes.">Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.</a> Development. 118 (2), 401-415 (1993).</li><li>Jory, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+survey+of+6,300+genomic+fragments+for+cis-regulatory+activity+in+the+imaginal+discs+of+Drosophila+melanogaster.">A survey of 6,300 genomic fragments for cis-regulatory activity in the imaginal discs of Drosophila melanogaster.</a> Cell Rep. 2 (4), 1014-1024 (2012).</li><li>McGuire, S. E., Le, P. T., Osborn, A. J., Matsumoto, K., Davis, R. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Spatiotemporal+rescue+of+memory+dysfunction+in+Drosophila.">Spatiotemporal rescue of memory dysfunction in Drosophila.</a> Science. 302 (5651), 1765-1768 (2003).</li><li>Rodrigues, A. B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Activated+STAT+regulates+growth+and+induces+competitive+interactions+independently+of+Myc,+Yorkie,+Wingless+and+ribosome+biogenesis.">Activated STAT regulates growth and induces competitive interactions independently of Myc, Yorkie, Wingless and ribosome biogenesis.</a> Development. 139 (21), 4051-4061 (2012).</li><li>Khan, S. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Epithelial+neoplasia+in+Drosophila+entails+switch+to+primitive+cell+states.">Epithelial neoplasia in Drosophila entails switch to primitive cell states.</a> Proc Natl Acad Sci U S A. 110 (24), E2163-E2172 (2013).</li><li>Pagliarini, R. A., Xu, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+genetic+screen+in+Drosophila+for+metastatic+behavior.">A genetic screen in Drosophila for metastatic behavior.</a> Science. 302 (5648), 1227-1231 (2003).</li><li>Gonzalez, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Drosophila+melanogaster:+a+model+and+a+tool+to+investigate+malignancy+and+identify+new+therapeutics.">Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics.</a> Nat Rev Cancer. 13 (3), 172-183 (2013).</li><li>Patel, P. H., Edgar, B. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Tissue+design:+how+Drosophila+tumors+remodel+their+neighborhood.">Tissue design: how Drosophila tumors remodel their neighborhood.</a> Semin Cell Dev Biol. 28, 86-95 (2014).</li><li>Nakajima, Y. -. I., Meyer, E. J., Kroesen, A., McKinney, S. A., Gibson, M. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Epithelial+junctions+maintain+tissue+architecture+by+directing+planar+spindle+orientation.">Epithelial junctions maintain tissue architecture by directing planar spindle orientation.</a> Nature. 500 (7462), 359-362 (2013).</li><li>Colombani, J., Andersen, D. S., L&#233;opold, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Secreted+peptide+Dilp8+coordinates+Drosophila+tissue+growth+with+developmental+timing.">Secreted peptide Dilp8 coordinates Drosophila tissue growth with developmental timing.</a> Science. 336 (6081), 582-585 (2012).</li><li>Garelli, A., Gontijo, A. M., Miguela, V., Caparros, E., Dominguez, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Imaginal+discs+secrete+insulin-like+peptide+8+to+mediate+plasticity+of+growth+and+maturation.">Imaginal discs secrete insulin-like peptide 8 to mediate plasticity of growth and maturation.</a> Science. 336 (6081), 579-582 (2012).</li></ol>

The GAL4-UAS system is one of the most powerful genetic tools for targeted gene expression in Drosophila 26 and greatly facilitates tumor cell induction and analysis in vivo 4. This system enables the generation of clones bearing knockdown of tumor-suppressor genes or overexpression of oncogenes within wild-type epithelial tissue, a situation highly similar to the initial stages of human cancer where transformed pro-tumor cells are surrounded by normal epi...

Epithelial tissues are highly organized systems that have the remarkable homeostatic ability to maintain their organization through development and cell turnover. This robust self-organizing system, however, is progressively disrupted during tumor development. At the beginning of tumor development, individual mutant cells arising from oncogene activation or tumor-suppressor gene inactivation emerge within an epithelial layer. When this transformed &#34;pro-tumor cell&#34; evades a suppressive environment, disrupts epithelial organization, and begins uncontrolled proliferation, tumorigenesis occurs 1. During the past few decades, outstanding technological advances in genetics and molecular biology have made remarkable progresses on cancer research. In particular, recent studies using the genetically mosaic analysis tools in Drosophila melanogaster, such as FLP-FRT (flippase recombinase/flippase recombinase target) mitotic recombination 2 and flip-out-GAL4-UAS (upstream activating sequence) systems 3, have greatly contributed to better understanding the genetic mechanisms involved in the formation and metastasis of tumors 4,5,6.
Studies of a group of conserved Drosophila tumor-suppressor genes, lethal giant larvae (lgl), discs large (dlg), and scribble (scrib), highlighted the critical relationship between loss of epithelial organization and tumor development, as these genes play key roles in regulation of apical-basal cell polarity and cell proliferation in epithelial tissues 7. While Drosophila imaginal discs are normally monolayered epithelia, homozygous mutations in any of these three genes cause cells to lose structure and polarity, fail to differentiate, overproliferate, and ultimately form multilayered amorphous masses that fuse with adjacent tissues 7. Similarly, disruption of these genes in mammals is involved in the development of malignant tumors 8,9. The neoplastic phenotypes exhibited by the mutant tissues have led to the classification of these three genes as conserved, neoplastic tumor-suppressor genes (nTSGs) 7,8. However, when homozygous nTSG mutant cells are sporadically generated in developing wild-type imaginal discs using FLP-FRT-mediated mitotic recombination, mutant cells are eliminated from the tissue through c-Jun N-terminal kinase (JNK)-dependent apoptosis 10,11,12,13,14, extrusion 15,16, or engulfment and phagocytosis by neighbors 17. In this genetically mosaic epithelia, apoptosis is mostly detected in nTSG mutant cells located at the clone boundary, suggesting that adjacent normal cells trigger the apoptosis of nTSG mutant cells 10,11,12,18. Recent studies in mammalian cells have confirmed that this cell competition-dependent elimination of pro-tumor cells is an evolutionarily conserved epithelial self-defense mechanism against cancer 19,20,21,22,23.
A recent study in Drosophila imaginal discs, however, showed that mosaic nTSG-knockdown clones induces neoplastic tumors in specific regions of wing imaginal discs 16. Initial tumor formation was always found in the peripheral &#34;hinge&#34; region and never observed in the central &#34;pouch&#34; region of the wing disc epithelium, suggesting that the tumorigenic potential of nTSG-knockdown cells depends on the local environment. The central pouch region functions as a &#34;tumor coldspot&#34; where pro-tumor cells do not show dysplastic overgrowth, whereas the peripheral hinge region behaves as a &#34;tumor hotspot&#34; 16. In &#34;coldspot&#34; pouch regions, nTSG-knockdown cells delaminate from the basal side and undergo apoptosis. In contrast, as &#34;hotspot&#34; hinge cells possess a network of robust cytoskeletal structures on their basal sides, nTSG-knockdown cells delaminate from the apical side of the epithelium and initiate tumorigenic overgrowth 16. Therefore, analysis of tumor phenotypes in imaginal discs requires careful consideration of the region-specific susceptibility to tumorigenic stimuli.
Here, we describe a protocol to induce neoplastic tumor formation in the Drosophila wing imaginal discs utilizing the GAL4-UAS-RNAi system by which nTSG-knockdown cells are generated in normal wing disc epithelia. Although these experimental systems are useful to study the early stages of cancer, a clear classification method to evaluate the stages of tumor progression in imaginal disc epithelia has not been clearly described before. Therefore, we also propose a diagnosis method to classify pro-tumor clonal phenotypes induced in the wing disc epithelia into three categories: hyperplasia (accumulation of an excessive number of normal-appearing cells with increased proliferation), dysplasia (premalignant tissue composed of abnormally appearing cells), and neoplasia (benign or malignant tumor composed of cells having an abnormal appearance and abnormal proliferation pattern).

<table>
	<tbody>
		<tr>
			<td>Reagents</td>
			<td></td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<td>Phosphate buffered saline (PBS)</td>
			<td>Wako</td>
			<td>162-19321</td>
			<td></td>
		</tr>
		<tr>
			<td>TritonX-100</td>
			<td>Wako</td>
			<td>168-11805</td>
			<td></td>
		</tr>
		<tr>
			<td>Formaldehyde</td>
			<td>Wako</td>
			<td>064-00406</td>
			<td></td>
		</tr>
		<tr>
			<td>bovine serum albumin</td>
			<td>Sigma</td>
			<td>A7906</td>
			<td></td>
		</tr>
		<tr>
			<td>normal goat serum</td>
			<td>Sigma</td>
			<td>G6767</td>
			<td></td>
		</tr>
		<tr>
			<td>mounting medium, Vectashield</td>
			<td>Vector Laboratories</td>
			<td>H-1000</td>
			<td></td>
		</tr>
		<tr>
			<td>DAPI</td>
			<td>Sigma</td>
			<td>D9542</td>
			<td></td>
		</tr>
		<tr>
			<td>mouse-anti-Dlg 4F3</td>
			<td>Developmental Studies Hybridoma Bank</td>
			<td>4F3 anti-discs large, RRID:AB_528203</td>
			<td>dilute in PBTG, 1:40</td>
		</tr>
		<tr>
			<td>mouse-anti-MMP1</td>
			<td>Developmental Studies Hybridoma Bank</td>
			<td>3A6B4, RRID:AB_579780</td>
			<td>3 mixed 1:1:1 and dilute in PBTG, 1:40</td>
		</tr>
		<tr>
			<td>mouse-anti-MMP1</td>
			<td>Developmental Studies Hybridoma Bank</td>
			<td>3B8D12, RRID:AB_579781</td>
			<td>3 mixed 1:1:1 and dilute in PBTG, 1:40</td>
		</tr>
		<tr>
			<td>mouse-anti-MMP1</td>
			<td>Developmental Studies Hybridoma Bank</td>
			<td>5H7B11, RRID:AB_579779</td>
			<td>3 mixed 1:1:1 and dilute in PBTG, 1:40</td>
		</tr>
		<tr>
			<td>mouse-anti-atubulin</td>
			<td>Developmental Studies Hybridoma Bank</td>
			<td>AA4.3, RRID:AB_579793</td>
			<td>dilute in PBTG, 1:100</td>
		</tr>
		<tr>
			<td>Alexa Fluor 546 Phalloidin</td>
			<td>Molecular probes</td>
			<td>A22283</td>
			<td>dilute in PBS, 1:40</td>
		</tr>
		<tr>
			<td>goat anti-mouse IgG antibody, Alexa Fluor 546</td>
			<td>Molecular probes</td>
			<td>A11030</td>
			<td>dilute in PBTG, 1:400</td>
		</tr>
		<tr>
			<td>Name</td>
			<td>Company</td>
			<td>Catalog Number</td>
			<td>Comments</td>
		</tr>
		<tr>
			<td>Fly strains</td>
			<td></td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<td>sd-Gal4</td>
			<td>Bloomington Drosophila Stock Center</td>
			<td>#8609</td>
			<td>recombined with UAS-EGFP</td>
		</tr>
		<tr>
			<td>upd-Gal4</td>
			<td>Bloomington Drosophila Stock Center</td>
			<td>#26796</td>
			<td>recombined with UAS-EGFP</td>
		</tr>
		<tr>
			<td>UAS-lgl-RNAi</td>
			<td>Vienna Drosophila RNAi center</td>
			<td>#51247</td>
			<td></td>
		</tr>
		<tr>
			<td>UAS-scrib-RNAi</td>
			<td>Vienna Drosophila RNAi center</td>
			<td>#105412</td>
			<td></td>
		</tr>
		<tr>
			<td>UAS-RasV12</td>
			<td>Bloomington Drosophila Stock Center</td>
			<td>#64196</td>
			<td></td>
		</tr>
		<tr>
			<td>UAS-Yki3SA</td>
			<td>Bloomington Drosophila Stock Center</td>
			<td>#28817</td>
			<td></td>
		</tr>
		<tr>
			<td>hsFLP</td>
			<td>Bloomington Drosophila Stock Center</td>
			<td>#6</td>
			<td></td>
		</tr>
		<tr>
			<td>Act&#62;CD2&#62;GAL4 (flip-out GAL4)</td>
			<td>Bloomington Drosophila Stock Center</td>
			<td>#4780</td>
			<td>recombined with UAS-EGFP</td>
		</tr>
		<tr>
			<td>UAS-EGFP</td>
			<td>Bloomington Drosophila Stock Center</td>
			<td>#5428</td>
			<td>X chromosome</td>
		</tr>
		<tr>
			<td>UAS-EGFP</td>
			<td>Bloomington Drosophila Stock Center</td>
			<td>#6658</td>
			<td>third chromosome</td>
		</tr>
		<tr>
			<td>UAS-Dicer2</td>
			<td>Bloomington Drosophila Stock Center</td>
			<td>#24650</td>
			<td>second chromosome</td>
		</tr>
		<tr>
			<td>UAS-Dicer2</td>
			<td>Bloomington Drosophila Stock Center</td>
			<td>#24651</td>
			<td>third chromosome</td>
		</tr>
		<tr>
			<td>vkg-GFP</td>
			<td>Morin et al. 2001</td>
			<td></td>
			<td>GFP protein trap</td>
		</tr>
	</tbody>
</table>

induction and diagnosis of tumors in drosophila imaginal disc epithelia

In the early stages of cancer, transformed mutant cells show cytological abnormalities, begin uncontrolled overgrowth, and progressively disrupt tissue organization. Drosophila melanogaster has emerged as a popular experimental model system in cancer biology to study the genetic and cellular mechanisms of tumorigenesis. In particular, genetic tools for Drosophila imaginal discs (developing epithelia in larvae) enable the creation of transformed pro-tumor cells within a normal epithelial tissue, a situation similar to the initial stages of human cancer. A recent study of tumorigenesis in Drosophila wing imaginal discs, however, showed that tumor initiation depends on the tissue-intrinsic cytoarchitecture and the local microenvironment, suggesting that it is important to consider the region-specific susceptibility to tumorigenic stimuli in evaluating tumor phenotypes in imaginal discs. To facilitate phenotypic analysis of tumor progression in imaginal discs, here we describe a protocol for genetic experiments using the GAL4-UAS system to induce neoplastic tumors in wing imaginal discs. We further introduce a diagnosis method to classify the phenotypes of clonal lesions induced in imaginal epithelia, as a clear classification method to discriminate various stages of tumor progression (such as hyperplasia, dysplasia, or neoplasia) had not been described before. These methods might be broadly applicable to the clonal analysis of tumor phenotypes in various organs in Drosophila.

To demonstrate neoplastic tumor formation experimentally induced by RNAi-mediated nTSG-knockdown in Drosophila wing imaginal discs, three different GAL4 drivers were used to express UAS-RNAi for lgl or scrib: (1) sd-GAL4, which drives strong UAS expression in the wing pouch and mild expression in the hinge regions (Figure 2 and Figure 3A); (2) upd-GAL4, which drives i...

Watch this Scientific Journal Video about Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia at JoVE.com

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia

Mosaic clone analysis in Drosophila imaginal disc epithelia is a powerful model system to study the genetic and cellular mechanisms of tumorigenesis. Here we describe a protocol to induce tumors in Drosophila wing imaginal discs using the GAL4-UAS system, and introduce a diagnosis method to classify the tumor phenotypes.

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia

In the early stages of cancer, transformed mutant cells show cytological abnormalities, begin uncontrolled overgrowth, and progressively disrupt tissue ...

The overall goal of this procedure, is to generate tumerogenic mosaic clones in developing Drosophila imaginal discs, and then classify the clonal lesions into various stages of tumor development. This method can help answer a key question in cancer modeling. Such as how to consistently induce tumors, and how to classify the stage of progression.The main advantages of this technique are that tumor injection in the Drosophila wing imaginal disks is accomplished using simple fly genetics, and that, classification of the tumor development stages is a simple diagnosis. Along with Kenta Morimoto, demonstrating the procedure, will be Kimiko Morimoto, a technician from my laboratory. Begin with setting up the genetic cross.12 hours before collecting virgins for the cross, clear all the adult flies from vials containing mature pupae. The following day, set up a cross to generate genetically-mosaic progeny. Transfer 12 to 20 virgins, and 10 males, into a fresh vial, and incubate them for one day at 25 degrees Celsius.After 24 hours, transfer the flies into a fresh vial, and discard the first vial they populated. After 12 more hours, eggs will start becoming available. On 12-hour intervals transfer the adults to new vials, and use the progeny for the experiment.After incubating egg vials for two to four days at 25 degrees Celsius, heat-shock the larvae for ten to 45 minutes, using a 37-degree Celsius water bath, for induction of mosaic clones by flip-out GAL4. Heat-shocking at two days of development will generate clones in immature discs. Heat-shocking at three or four days of development, will generate clones in more later-stage discs.After the heat-shock, return the vials to the 25-degree Celsius incubator, until the third-instar larvae are available. To begin, use a wooden stick, or blunt forceps, to transfer wandering third-instar larvae into a Petri dish with PBS. Then, genotype them under fluorescent light to identify the appropriate fluorescent markers for mosaic larvae.Before proceeding, wash the larvae with PBS. Then, under a dissection microscope, use two pairs of forceps to pinch the center of the larva, and tear the body in half. Next, pinch the mouth hooks, while pushing the mouth towards the body, to turn the body inside-out.Then, remove unnecessary materials, such as the salivary glands and fat bodies. The larvae are now prepared for fixation and antibody staining, which is detailed in the text protocol. Transfer the stained tissue preparations to a microscope slide using a two-milliliter plastic transfer pipette.Then, using forceps, move individual larva into drops of mounting medium on a microscope slide. Now, using forceps, isolate the imaginal discs. Start with holding down the end of dissected tissue, and pulling away the brain and eye-antennal discs with the other forceps.Keep the brains ready for use. Now locate the wing imaginal discs. The wing imaginal discs are stuck to the lateral side of dissected tissue.Next, secure the tissue with one forcep, and gently scratch off the wing discs. Then, position the brains near the wing discs, to shield them from being crushed by the coverslip. Now, gently cover the structures with a coverslip, and seal the coverslip with nail polish.Store the slide at four degrees Celsius. After using a confocal microscope to acquire the confocal Z-stack images, open them in ImageJ, and use the Reslice command to create virtual sections. They can be made on the X-Z axis, the Y-Z axis, or in a customized plane.To create the customized plane, draw a straight line, or rectangle, onto the Z-stack image, And follow the prompts to make the computer generate its section. Use such sections to diagnose the tissue for tumor phenotypes. First, identify the cell masses that deviate, or shows outgrowth from the main epithelial layer.Then, for each mass, determine whether the sub-cellular localization of the junctional proteins appears normal. Other considerations include the size of the mass, and any indications of increased cell proliferation within the mass. Thus, the type of tumor is identified.In this example, four clones were classified, using vertical sections generated by the imaging software. Two were classified as dysplasia, because the labeled DLG protein was mis-localized. Clone B is less than four cells large, and Clone C does not deviate from the epithelium.Therefore, neither B or C were classified as a neoplasm. The other two clones also showed mis-localization of DLG, and formed tumorous cell-masses outside of the epithelium. As the size of these displaced tumorous clones was more than four cells in diameter, these clones were classified as neoplastic.Using the described methods, the gene LGL was knocked-down in the wing-pouch and the hinge regions, using sd-GAL4-driven RNAi. In controls lacking the RNAi transgene, there were no morphological alterations in the third-instar wing discs. In knock-downs, epithelial deformations and tumorogenic over-growths were clearly observed in certain parts of the hinge.However, dysplastic over-growth was not observed in the wing-pouch region. This correlated inversely with MMP1 expression in those regions:a protein that provides metastatic capability. To monitor the progression of tumor growth induced by LGL knock-down, sporadic clones, expressing LGL-RNAi were generated in wing discs, as described.Two days after heat-shock to second-instar larvae, some knock-down clones in the hinge region showed deviation from the apical side of the epithelial layer. Four days after heat-shock induction, dysplastic lesions in the hinge region became clear, suggesting that LGL knock-down clones, displaced from the apical side, proliferate in the lumen. Seven days after heat-shock induction, tumorogenic over-growths dominated the hinge regions.When using flip-out GAL4 systems, it's important to remember to examine the effect of altered heat-shock timing on clonal phenotypes, because the tumorogenic potential of imaginal disc cells may be dependent on the developmental stage endogenous signaling events, or cellular differentiation.

induction-diagnosis-tumors-drosophila-imaginal-disc

Research

JoVE Journal

Cancer Research

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

As our understanding of the driver mutations necessary for initiation and progression of cancers improves, we gain critical information on how specific molecular profiles of a tumor may predict responsiveness to therapeutic agents or provide knowledge about prognosis. At our institution a tumor genotyping program was established as part of routine clinical care, screening both hematologic and solid tumors for a wide spectrum of mutations using two next-generation sequencing (NGS) panels: a custom, 33 gene hematological malignancies panel for use with peripheral blood and bone marrow, and a commercially produced solid tumor panel for use with formalin-fixed paraffin-embedded tissue that targets 47 genes commonly mutated in cancer. Our workflow includes a pathologist review of the biopsy to ensure there is adequate amount of tumor for the assay followed by customized DNA extraction is performed on the specimen. Quality control of the specimen includes steps for quantity, quality and integrity and only after the extracted DNA passes these metrics an amplicon library is generated and sequenced. The resulting data is analyzed through an in-house bioinformatics pipeline and the variants are reviewed and interpreted for pathogenicity. Here we provide a snapshot of the utility of each panel using two clinical cases to provide insight into how a well-designed NGS workflow can contribute to optimizing clinical outcomes.

This manuscript describes clinical protocols for two next-generation sequencing panels. One panel interrogates hematologic malignancies while the other panel targets genes commonly mutated in solid tumors. Molecular classification of driver mutations in human malignancies offers valuable prognostic and predictive information.

As our understanding of the driver mutations necessary for initiation and progression of cancers improves, we gain critical information on how specific ...

The Drosophila Imaginal Disc Tumor Model: Visualization and Quantification of Gene Expression and Tumor Invasiveness Using Genetic Mosaics

Drosophila melanogaster has emerged as a powerful experimental system for functional and mechanistic studies of tumor development and progression in the context of a whole organism. Sophisticated techniques to generate genetic mosaics facilitate induction of visually marked, genetically defined clones surrounded by normal tissue. The clones can be analyzed through diverse molecular, cellular and omics approaches. This study describes how to generate fluorescently labeled clonal tumors of varying malignancy in the eye/antennal imaginal discs (EAD) of Drosophila larvae using the Mosaic Analysis with a Repressible Cell Marker (MARCM) technique. It describes procedures how to recover the mosaic EAD and brain from the larvae and how to process them for simultaneous imaging of fluorescent transgenic reporters and antibody staining. To facilitate molecular characterization of the mosaic tissue, we describe a protocol for isolation of total RNA from the EAD. The dissection procedure is suitable to recover EAD and brains from any larval stage. The fixation and staining protocol for imaginal discs works with a number of transgenic reporters and antibodies that recognize Drosophila proteins. The protocol for RNA isolation can be applied to various larval organs, whole larvae, and adult flies. Total RNA can be used for profiling of gene expression changes using candidate or genome-wide approaches. Finally, we detail a method for quantifying invasiveness of the clonal tumors. Although this method has limited use, its underlying concept is broadly applicable to other quantitative studies where cognitive bias must be avoided.

The Drosophila Imaginal Disc Tumor Model: Visualization and Quantification of Gene Expression and Tumor Invasiveness Using Genetic Mosaics

This protocol demonstrates how to generate fluorescently marked, genetically defined clonal tumors in the Drosophila eye/antennal imaginal discs (EAD). It describes how to dissect the EAD and brain from the third instar larvae and how to process them to visualize and quantify gene expression changes and tumor invasiveness.

Drosophila melanogaster has emerged as a powerful experimental system for functional and mechanistic studies of tumor development and progression in the ...

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

The crosstalk between tumor cells and bone cells in the bone microenvironment is crucial to understanding the mechanism of bone metastasis formation. We developed an in vitro fully human preclinical model of a co-culture of breast cancer cells and monocytes undergoing differentiation towards osteoclasts. We optimized a model of osteoclastogenesis starting from a sample of peripheral blood collected from healthy donors. Peripheral blood mononuclear cells (PBMCs) were first separated by density gradient centrifugation, seeded at a high density and induced to differentiate by adding two growth factors (GFs): receptor activator of nuclear factor-&#954;B ligand (RANKL) and macrophage colony-stimulating factor (MCSF). The cells were left in culture for 14 days and then fixed and analyzed by downstream analysis. In osteolytic bone metastases, one of the effects of cancer cell arrival in bone is the induction of osteoclastogenesis. We thus challenged our model with co-cultures of breast cancer cells to study the differentiation power of cancer cells with respect to GFs. A straightforward way of studying cancer cell-osteoclast interaction is to perform indirect co-cultures based on the use of conditioned medium collected from breast cancer cell cultures and mixed with fresh medium. This mixture is then used to induce osteoclast differentiation. We also optimized a method of direct co-culture in which cancer cells and monocytes undergoing differentiation share the medium and exchange secreted factors. This is a significant improvement over the original indirect co-culture method as researchers can observe the reciprocal interactions of the two cell types and perform downstream analyses for both cancer cells and osteoclasts. This method enables us to study the effect of drugs on the metastatic bone microenvironment and to seed cell lines other than those derived from breast cancer. The model can also be used to study other diseases such as osteoporosis or other bone conditions.

This protocol describes development of an in vitro human preclinical model of osteoclastogenesis from peripheral blood monocytes cultured with breast cancer cell lines to mimic the cancer cell-osteoclast interaction. The model could be used to further our understanding of bone metastasis formation and improve therapeutic options.

The crosstalk between tumor cells and bone cells in the bone microenvironment is crucial to understanding the mechanism of bone metastasis formation. We ...

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Soft tissue sarcomas (STS) represent a spectrum of heterogeneous malignancies with a difficult diagnosis, classification, and management. To date, more than 50 histological subtypes of these rare solid tumors have been identified. Thus, due to their extraordinary diversity and low incidence, our understanding of the biology of these tumors is still limited. Patient-derived cultures represent the ideal platform to study STS pathophysiology and pharmacology. We thus developed a human preclinical model of STS starting from tumor specimens harvested from patients undergoing surgical resection. Patient-derived STS cell cultures were obtained from the surgical specimens by collagenase digestion and isolated by filtration. Cells were counted, seeded, and left for 14 days in standard monolayer cultures and then processed by downstream analysis. Before performing molecular or pharmaceutical analyses, the establishment of STS primary cultures was confirmed through the evaluation of cytomorphologic features and, when available, immunohistochemical markers. This method represents a useful tool 1) to study the natural history of these poorly explored malignancies and 2) to test the effects of different drugs in an effort to learn more about their mechanisms of action.

The following protocol focuses on the establishment of a primary culture of patient-derived soft tissue sarcoma (STS). This model could help us to better understand the molecular background and pharmacological profile of these rare malignancies and could represent a starting point for further research aimed at improving STS management.

Soft tissue sarcomas (STS) represent a spectrum of heterogeneous malignancies with a difficult diagnosis, classification, and management. To date, more ...

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

The tumor immune microenvironment (TIME) has recently been recognized as a critical mediator of treatment response in solid tumors, especially for immunotherapies. Recent clinical advances in immunotherapy highlight the need for reproducible methods to accurately and thoroughly characterize the tumor and its associated immune infiltrate. Tumor enzymatic digestion and flow cytometric analysis allow broad characterization of numerous immune cell subsets and phenotypes; however, depth of analysis is often limited by fluorophore restrictions on panel design and the need to acquire large tumor samples to observe rare immune populations of interest. Thus, we have developed an effective and high throughput method for separating and enriching the tumor immune infiltrate from the non-immune tumor components. The described tumor digestion and centrifugal density-based separation technique allows separate characterization of tumor and tumor immune infiltrate fractions and preserves cellular viability, and thus, provides a broad characterization of the tumor immunologic state. This method was used to characterize the extensive spatial immune heterogeneity in solid tumors, which further demonstrates the need for consistent whole tumor immunologic profiling techniques. Overall, this method provides an effective and adaptable technique for the immunologic characterization of subcutaneous solid murine tumors; as such, this tool can be used to better characterize the tumoral immunologic features and in the preclinical evaluation of novel immunotherapeutic strategies.

Here we describe a method to separate and enrich components of the tumor immune and non-immune microenvironment in established subcutaneous tumors. This technique allows for the separate analysis of tumor immune infiltrate and non-immune tumor fractions which can permit comprehensive characterization of the tumor immune microenvironment.

The tumor immune microenvironment (TIME) has recently been recognized as a critical mediator of treatment response in solid tumors, especially for ...

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury

Liver ischemia and reperfusion (I/R) injury, a common clinical challenge, remains an inevitable pathophysiological process that has been shown to induce multiple tissue and organ damage. Despite recent advances and therapeutic approaches, the overall morbidity has remained unsatisfactory especially in patients with underlying parenchymal abnormalities. In the context of aggressive cancer growth and metastasis, surgical I/R is suspected to be the promoter regulating tumor recurrence. This article aims to describe a clinically relevant murine model of liver I/R and colorectal liver metastasis. In doing so, we aim to assist other investigators in establishing and perfecting this model for their routine research practice to better understand the effects of liver I/R on promoting liver metastases.

We describe in detail a clinically relevant colorectal cancer liver metastases (CRLM) tumor model and the influence of liver ischemia reperfusion (I/R) in tumor growth and metastasis. This model can help to better understand the mechanisms underlying surgery-induced promotion of liver metastatic growth.

Liver ischemia and reperfusion (I/R) injury, a common clinical challenge, remains an inevitable pathophysiological process that has been shown to induce ...

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Cancer stem cells (CSC) are a small population with self-renewal and plasticity which are responsible for tumorigenesis, resistance to treatment and recurrent disease. This population can be identified by surface markers, enzymatic activity and a functional profile. These approaches per se are limited, due to phenotypic heterogeneity and CSC plasticity. Here, we update the sphere-forming protocol to obtain CSC spheres from breast and gynecological cancers, assessing functional properties, CSC markers and protein expression. The spheres are obtained with single-cell seeding at low density in suspension culture, using a semi-solid methylcellulose medium to avoid migration and aggregates. This profitable protocol can be used in cancer cell lines but also in primary tumors. The tridimensional non-adherent suspension culture thought to mimic the tumor microenvironment, particularly the CSC-niche, is supplemented with epidermal growth factor and basic fibroblast growth factor to ensure CSC signaling. Aiming for robust identification of CSC, we propose a complementary approach, combining functional and phenotypic evaluation. Sphere-forming capacity, self-renewal and sphere projection area establish CSC functional properties. Additionally, characterization comprises flow cytometry evaluation of the markers, represented by CD44+/CD24- and CD133, and Western blot, considering ALDH. The presented protocol was also optimized for primary tumor samples, following a sample digestion procedure, useful for translational research.

The aim of this methodology is to identify cancer stem cells (CSC) in cancer cell lines and primary human tumor samples with the sphere-forming protocol, in a robust manner, using functional assays and phenotypic characterization with flow cytometry and Western blot.

Cancer stem cells (CSC) are a small population with self-renewal and plasticity which are responsible for tumorigenesis, resistance to treatment and ...

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Preclinical models that faithfully recapitulate tumor heterogeneity and therapeutic response are critical for translational breast cancer research. Immortalized cell lines are easy to grow and genetically modify to study molecular mechanisms, yet the selective pressure from cell culture often leads to genetic and epigenetic alterations over time. Patient-derived xenograft (PDX) models faithfully recapitulate the heterogeneity and drug response of human breast tumors. PDX models exhibit a relatively short latency after orthotopic transplantation that facilitates the investigation of breast tumor biology and drug response. The transplantable genetically engineered mouse models allow the study of breast tumor immunity. The current protocol describes the method to orthotopically transplant breast tumor fragments into the mammary fat pad followed by drug treatments. These preclinical models provide valuable approaches to investigate breast tumor biology, drug response, biomarker discovery and mechanisms of drug resistance.

Patient-derived xenograft (PDX) models and transplantable genetically engineered mouse models faithfully recapitulate human disease and are preferred models for basic and translational breast cancer research. Here, a method is described to orthotopically transplant breast tumor fragments into the mammary fat pad to study tumor biology and evaluate drug response.

Preclinical models that faithfully recapitulate tumor heterogeneity and therapeutic response are critical for translational breast cancer research. ...

Quail Chorioallantoic Membrane - A Tool for Photodynamic Diagnosis and Therapy

The chorioallantoic membrane (CAM) of an avian embryo is a thin, extraembryonic membrane that functions as a primary respiratory organ. Its properties make it an excellent in vivo experimental model to study angiogenesis, tumor growth, drug delivery systems, or photodynamic diagnosis (PDD) and photodynamic therapy (PDT). At the same time, this model addresses the requirement for the replacement of experimental animals with a suitable alternative. Ex ovo cultivated embryo allows easy substance application, access, monitoring, and documentation. The most frequently used is chick CAM; however, this article describes the advantages of the Japanese quail CAM as a low-cost and high-throughput model. Another advantage is the shorter embryonic development, which allows higher experimental turnover. The suitability of quail CAM for PDD and PDT of cancer and microbial infections is explored here. As an example, the use of the photosensitizer hypericin in combination with lipoproteins or nanoparticles as a delivery system is described. The damage score from images in white light and changes in fluorescence intensity of the CAM tissue under violet light (405 nm) was determined, together with analysis of histological sections. The quail CAM clearly showed the effect of PDT on the vasculature and tissue. Moreover, changes like capillary hemorrhage, thrombosis, lysis of small vessels, and bleeding of larger vessels could be observed. Japanese quail CAM is a promising in vivo model for photodynamic diagnosis and therapy research, with applications in studies of tumor angiogenesis, as well as antivascular and antimicrobial therapy.

The chorioallantoic membrane (CAM) of the avian embryo is a very useful and applicable tool for various areas of research. A special ex ovo model of Japanese quail CAM is suitable for photodynamic treatment investigation.

The chorioallantoic membrane (CAM) of an avian embryo is a thin, extraembryonic membrane that functions as a primary respiratory organ. Its properties ...

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model

Anaplastic thyroid carcinoma (ATC) is associated with a poor prognosis and short median survival time, but no effective treatment improves the outcomes significantly. Genetically engineered murine models that mimic ATC&#39;s progression may help researchers to study treatments for this disease. Crossing three different genotypes of mice, a TPO-cre/ERT2; BrafCA/wt; Trp53&#916;ex2-10/&#916;ex2-10&#160;transgenic ATC model was developed. The ATC murine model was induced by an intraperitoneal injection of tamoxifen with overexpression of BrafV600E and deletion of Trp53, and the tumors were generated within about 1 month. High-resolution ultrasound was applied to investigate the tumor initiation and progression, and the dynamic growth curve was obtained by measuring the tumor sizes. Compared to magnetic resonance imaging (MRI) and computed tomography scanning, ultrasound has advantages in observing the ATC murine model, such as being noninvasive, portable, in real-time, and without radiation exposure. High-resolution ultrasound is suitable for dynamic and multiple measurements. However, ultrasonographic examination of the thyroid in mice requires relevant anatomical knowledge and experience. This article provides a detailed procedure for utilizing high-resolution ultrasound to scan tumors in the transgenic ATC model. Meanwhile, ultrasonic parameter adjustment, ultrasound scanning skills, anesthesia and recovery of the animals, and other elements that need attention during the process are listed.

The present protocol describes high-frequency ultrasonography for visualizing the entire mouse thyroid gland and monitoring the growth of anaplastic thyroid carcinoma.

Anaplastic thyroid carcinoma (ATC) is associated with a poor prognosis and short median survival time, but no effective treatment improves the outcomes ...